Portfolio company
Nuvaira
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Nuvaira develops a catheter-based lung denervation system to treat patients with chronic obstructive pulmonary disease by disrupting overactive airway nerves.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ryme Medical
The company develops catheter-based therapies for patients with chronic obstructive pulmonary disease to improve airflow and reduce symptoms through targeted lung denervation.
Neurent Medical
This company develops radiofrequency ablation systems used by clinicians to treat chronic rhinitis by disrupting overactive nerves within the nasal cavity.
Pulmonx
The company manufactures endobronchial valves used by healthcare professionals to treat patients with severe emphysema and chronic obstructive pulmonary disease.
SoniVie
SoniVie develops ultrasound-based intravascular denervation systems to treat patients with hypertensive disorders, including resistant hypertension and pulmonary arterial hypertension.
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
Spiro Medical
Spiro Medical develops an implantable neuromodulation system to treat patients with severe asthma and other chronic respiratory conditions.
Corveus
This company develops a catheter-based medical device for nerve ablation to treat patients suffering from congestive heart failure.
AirNexis
This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.
